Essential oils as potential anti-staphylococcal agents - Publikacja - MOST Wiedzy

Twoje konto

zaloguj

Wyszukiwarka

Essential oils as potential anti-staphylococcal agents

Abstrakt

Antibiotic therapy of staphylococcal mastitis is characterized by significantly lower cure rates compared to infections caused by other microorganisms. Thus, it is necessary to search for new, alternative, non-antibiotic agents that are effective in the eradication of these bacteria. The aim of our research was to investigate the antimicrobial, especially anti-staphylococcal potential of a large collection (n=36) of essential oils (EOs). Investigation of the antimicrobial activity of tested oils was determined by using a serial, twofold dilution method in 96-wells microtiter plates under conditions recommended by the Clinical and Laboratory Standards Institute (CLSI). The preliminary analysis revealed that six oils, namely: Manuka, Thyme, Geranium, Cedar, Cinnamon (from bark) and Patchouli exhibited the highest activity against reference strains of bacteria. Significant anti-staphylococcal potential of these oils has been also confirmed for a group of 18 Staphylococcus aureus, 8 Staphylococcus epidermidis and 5 Staphylococcus xylosus strains isolated from cases of bovine mastitis. Especially high activity was observed for Cedar, Patchouli, Thyme and Manuka oils. The MIC (Minimal Inhibitory Concentration) values for Patchouli oil were in the concentrations range of 0.01 to 0.313% (v/v). The three other oils inhibited the growth of staphylococci isolated from mastitis in the concentrations range of 0.01 to 0.625% (v/v). Oils isolated from Cinnamomum cassia and Pelargonium graveolens revealed a bit lower, but still satisfactory activity (MIC values in the concentrations range of 0.02 to 1.25% (v/v) and from 0.078 to 1.25% (v/v), respectively). In many cases a slightly higher concentration of oils was required to obtain the bactericidal effect in comparison to growth inhibition. The time – kill kinetic assay revealed that the bactericidal effect was achieved after two hours incubation of the reference strain S. aureus PCM 2051 cells with Thyme oil at concentration equal to 2xMIC (1.25% (v/v)) or MIC (0.625% (v/v)). A slightly lower activity was observed in the case of Cinnamon oil, the bactericidal effect was achieved after 8 hours of incubation. The results of our research clearly indicate that some essential oils exhibit a promising antimicrobial activity and can be considered as alternative antistaphylococcal agents.

Cytowania

  • 1 9

    CrossRef

  • 0

    Web of Science

  • 1 9

    Scopus

Autorzy (5)

Cytuj jako

Pełna treść

pobierz publikację
pobrano 110 razy
Wersja publikacji
Accepted albo Published Version
Licencja
Creative Commons: CC-BY-NC-ND otwiera się w nowej karcie

Słowa kluczowe

Informacje szczegółowe

Kategoria:
Publikacja w czasopiśmie
Typ:
artykuł w czasopiśmie wyróżnionym w JCR
Opublikowano w:
ACTA VETERINARIA-BEOGRAD nr 68, strony 95 - 107,
ISSN: 0567-8315
Język:
angielski
Rok wydania:
2018
Opis bibliograficzny:
Szweda P., Zalewska M., Pilch J., Kot B., Milewski S.: Essential oils as potential anti-staphylococcal agents// ACTA VETERINARIA-BEOGRAD. -Vol. 68, iss. 1 (2018), s.95-107
DOI:
Cyfrowy identyfikator dokumentu elektronicznego (otwiera się w nowej karcie) 10.2478/acve-2018-0008
Bibliografia: test
  1. Bochniarz M, Wawron W: Antibiotic susceptibility of methicillin-resistant and methicillin- susceptible coagulase-negative staphylococci isolated from bovine mastitis. Pol J Vet Sci 2011, 14(3): 405-410. otwiera się w nowej karcie
  2. Bochniarz M, Adaszek Ł, Dzięgiel B, Nowaczek A, Wawron W, Dąbrowski R, Szczubiał M, Winiarczyk S: Factors responsible for subclinical mastitis in cows caused by Staphylococcus chromogenes and its susceptibility to antibiotics based on bap, fnbA, eno, mecA, tetK, and ermA genes. J Dairy Sci 2016, 99(12): 9514-9520. otwiera się w nowej karcie
  3. Jagielski T, Puacz E, Lisowski A, Siedlecki P, Dudziak W, Międzobrodzki J, Krukowski H: Antimicrobial susceptibility profiling and genotyping of Staphylococcus aureus isolates from bovine mastitis in Poland. J Dairy Sci 2014, 97(10): 6122-6128. otwiera się w nowej karcie
  4. Kot B, Piechota M, Wolska KM, Frankowska A, Zdunek E, Binek T, Kłopotowska E, Antosiewicz M: Phenotypic and genotypic antimicrobial resistance of staphylococci from bovine milk. Pol J Vet Sci 2012, 15(4): 677-683. otwiera się w nowej karcie
  5. Kot B, Piechota M, Antos-Bielska M, Zdunek E, Wolska KM, Binek T, Olszewska J, Guliński P, Trafny EA: Antimicrobial resistance and genotypes of staphylococci from bovine milk and the cowshed environment. Pol J Vet Sci 2012, 15(4): 741-749. otwiera się w nowej karcie
  6. Szweda P, Schielmann M, Frankowska A, Kot B, Zalewska: Antibiotic resistance in Staphylococcus aureus strains isolated from cows with mastitis in eastern Poland and analysis of susceptibility of resistant strains to alternative nonantibiotic agents: lysostaphin, nisin and polymyxin B. J Vet Med Sci 2014, 76(3): 355-362. otwiera się w nowej karcie
  7. Nascimento JS, Ceotto H, Nascimento SB, Giambiagi-Demarval M, Santos KR, Bastos MC: Bacteriocins as alternative agents for control of multiresistant staphylococcal strains. Lett Appl Microbiol 2006, 42: 215-221. otwiera się w nowej karcie
  8. Szweda P, Schielmann M, Kotlowski R, Gorczyca G, Zalewska M, Milewski S: Peptidoglycan hydrolases-potential weapons against Staphylococcus aureus. Appl Microbiol Biotechnol 2012, 96: 1157-1174. otwiera się w nowej karcie
  9. Matsuzaki S, Yasuda M, Nishikawa H, Kuroda M, Ujihara T, Shuin T, Shen Y, Jin Z, Fujimoto S, Nasimuzzaman MD, Wakiguchi H, Sugihara S, Sugiura T, Koda S, Muraoka A, Imai S: Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11. J Infect Dis 2003, 187: 613-624. otwiera się w nowej karcie
  10. Sulakvelidze A, Alavidze Z, Morris JG: Bacteriophage therapy. Antimicrob Agents Chemother 2001, 45: 649-659. otwiera się w nowej karcie
  11. Desbois AP, Gemmell CG, Coote PJ: In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin- resistant Staphylococcus aureus (MRSA) infections. Int J Antimicrob Agents 2010, 35: 559-565. otwiera się w nowej karcie
  12. Korkina LG: Phenylpropanoids as naturally occurring antioxidants: from plant defense to human health. Cell Mol Biol 2007, (Noisy-le-grand) 53: 15-25.
  13. Mayaud L, Carricajo A, Zhiri A, Aubert G: Comparison of bacteriostatic and bactericidal activity of 13 essential oils against strains with varying sensitivity to antibiotics. Lett Appl Microbiol 2008, 47: 167-173. otwiera się w nowej karcie
  14. Orhan DD, Ozçelik B, Ozgen S, Ergun F: Antibacterial, antifungal, and antiviral activities of some flavonoids. Microbiolo Res 2010, 165: 496-504. otwiera się w nowej karcie
  15. Ewnetu Y, Lemma W, Birhane N: Antibacterial effects of Apis mellifera and stingless bees honeys on susceptible and resistant strains of Escherichia coli, Staphylococcus aureus and Klebsiella pneumoniae in Gondar, Northwest Ethiopia. BMC Complement Altern Med 2013, 13: 269. otwiera się w nowej karcie
  16. Szweda P, Kot B: Bee products and essential oils as alternative agents for treatment of infections caused by S. aureus, Frontiers in Staphylococcus aureus, Dr. Shymaa Enany (Ed.), InTech 2016, DOI: 10.5772/65978. otwiera się w nowej karcie
  17. Wojtyczka RD, Dziedzic A, Idzik D, Kepa M, Kubina R, Kabała-Dzik A, Smolen-Dzirba J, Stojko J, Sajewicz M, Wasik TJ: Susceptibility of Staphylococcus aureus clinical isolates to propolis extract alone or in combination with antimicrobial drugs. Molecules 2013, 18: 9623-9640. otwiera się w nowej karcie
  18. Kurlenda J, Grinholc M: Alternative therapies in Staphylococcus aureus diseases. Acta Bioch Pol 2012, 59: 171-184. otwiera się w nowej karcie
  19. Bakkali F, Averbeck S, Averbeck D, Idaomar M: Biological effects of essential oils -A review. Food Chem Toxicol 2008, 46: 446-475. otwiera się w nowej karcie
  20. Szweda P, Gucwa K, Kurzyk E, Romanowska E, Dzierżanowska-Fangrat K, Zielińska- Jurek A, Kuś PM, Milewsk S: Essential Oils, Silver Nanoparticles and Propolis as Alternative Agents Against Fluconazole Resistant Candida albicans, Candida glabrata and Candida krusei Clinical Isolates. Indian J Microbiol 2015, 55: 175-183. otwiera się w nowej karcie
  21. Shin S, Kim JH: In vitro inhibitory activities of essential oils from two Korean thymus species against antibiotic-resistant pathogens. Arch Pharm Res 2005, 28: 897-901. otwiera się w nowej karcie
  22. Tohidpour A, Sattari M, Omidbaigi R, Yadegar A, Nazemi J: Antibacterial effect of essential oils from two medicinal plants against Methicillin-resistant Staphylococcus aureus (MRSA). Phytomedicine 2010, 17: 142-145. otwiera się w nowej karcie
  23. Ooi LSM, Li Y, Kam S-L, Wang H, Wong EY, Ooi VE: Antimicrobial activities of cinnamon oil and cinnamaldehyde from the Chinese medicinal herb Cinnamomum cassia Blume. Am J Chin Med 2006, 34: 511-522. otwiera się w nowej karcie
  24. Melo ADB, Amaral AF, Schaefer G, Luciano FB, de Andrare C, Costa LB, Rostagno MH: Antimicrobial effect against different bacterial strains and bacterial adaptation to essential oils used as feed additives. Can J Vet Res 2015, 79: 285-289.
  25. Bigos M, Wasiela M, Kalemba D, Sienkiewicz M: Antimicrobial activity of geranium oil against clinical strains of Staphylococcus aureus. Molecules 2012, 7(9):10276-10291 otwiera się w nowej karcie
  26. Doran AL, Morden WE, Dunn K, Edwards-Jones V: Vapour-phase activities of essential oils against antibiotic sensitive and resistant bacteria including MRSA. Lett Appl Microbiol 2009, 48(4): 387-392. otwiera się w nowej karcie
  27. Harkenthal M, Reichling J, Geiss HK, Saller R: Comparative study on the in vitro antibacterial activity of Australian tea tree oil, cajuput oil, niaouli oil, manuka oil, kanuka oil, and eucalyptus oil. Pharmazie 1999, 54: 460-463.
  28. Song C-Y, Nam E-H, Park S-H, Hwang C-Y: In vitro efficacy of the essential oil from Leptospermum scoparium (manuka) on antimicrobial susceptibility and biofilm formation in Staphylococcus pseudintermedius isolates from dogs. Vet Dermatol 2013, 24: 404-408. otwiera się w nowej karcie
  29. Fratini F, Mancini S, Turchi B, Friscia E, Pistelli L, Giusti G, Cerri D: A novel interpretation of the Fractional Inhibitory Concentration Index: The case Origanum vulgare L. and Leptospermum scoparium J. R. et G. Forst essential oils against Staphylococcus aureus strains. Microbiol Res 2017, 195: 11-17. otwiera się w nowej karcie
  30. Thoppil JE, Tajo A, Minija J, Deena MJ, Sreeranjini K, Leeja L, Sivadasan M, Alfarhan AH: Antimicrobial activity of the essential oils of three species of Pogostemon. J Environ Biol 2014, 35(5): 795-798.
  31. Peng F, Wan F, Xiong L, Peng C, Dai M, Chen J: In vitro and in vivo antibacterial activity of Pogostone. Chin Med J (Engl) 2014, 127(23): 4001-4005.
  32. Bilcu M, Grumezescu AM, Oprea AE, Popescu RC, Mogoșanu GD, Hristu R, Stanciu GA, Mihailescu DF, Lazar V, Bezirtzoglou E, Chifiriuc MC: Efficiency of vanilla, patchouli and ylang ylang essential oils stabilized by iron oxide@C14 nanostructures against bacterial adherence and biofilms formed by Staphylococcus aureus and Klebsiella pneumoniae clinical strains. Molecules 2014, 19(11): 17943-17956. otwiera się w nowej karcie
  33. Vázquez-Sánchez D, Cabo ML, Rodríguez-Herrera JJ: Antimicrobial activity of essential oils against Staphylococcus aureus biofilms. Food Sci Technol Int 2015, 21(8): 559-570. otwiera się w nowej karcie
  34. Carson CF, Cookson BD, Farrelly HD, Riley TV: Susceptibility of methicillin-resistant Staphylococcus aureus to the essential oil of Melaleuca alternifolia. J Antimicrob Chemother 1995, 35(3): 421-424. otwiera się w nowej karcie
  35. Roller S, Ernest N, Buckle J: The antimicrobial activity of high-necrodane and other lavender oils on methicillin-sensitive and -resistant Staphylococcus aureus (MSSA and MRSA). otwiera się w nowej karcie
  36. J Altern Complement Med 2009, 15(3): 275-279. otwiera się w nowej karcie
  37. ETERIČNA ULJA SA ANTISTAFILOKOKNIM POTENCIJALOM SZWEDA Piotr, ZALEWSKA Magdalena, PILCH Joanna, KOT Barbara, MILEWSKI Sławomir Antibiotska terapija stafilokoknih mastitisa se karakteriše značajno malim uspehom u poređenju sa terapijom ostalih oboljenja, bakterijske etiologije. Otuda je neophodno da se obavljaju ispitivanja novih, alternativnih supstanci koje ne spadaju u kategor- iju antibiotika, a koje su efikasne. Cilj studije je bio da se ispitaju antimikrobna, a naročito antistafilokokna svojstva većeg broja (n=36) eteričnih ulja (EO). Ispitivanje antimikrobnih svojstava testiranih ulja su određivana korišćenjem dvostrukih serijskih razređenja, u mikrotitar pločama (96 mesta), u preporučenim uslovima od strane In- stituta za kliničku i laboratorijsku standardizaciju (CLSI). Preliminarni rezultati su pokazali da šest ulja: manuka, majčina dušica, geranijum, kedar, cimet kao i pačuli
Weryfikacja:
Politechnika Gdańska

wyświetlono 299 razy

Publikacje, które mogą cię zainteresować

Essential Oils, Silver Nanoparticles and Propolis as Alternative Agents Against Fluconazole Resistant Candida albicans, Candida glabrata and Candida krusei Clinical Isolates

2015

Investigation of the Antifungal Activity and Mode of Action of Thymus vulgaris, Citrus limonum, Pelargonium graveolens, Cinnamomum cassia, Ocimum basilicum, and Eugenia caryophyllus Essential Oils

2018

Antibiotic resistance in Staphylococcus aureus strains isolated from cows with mastitis in the eastern Poland and analysis of susceptibility of resistant strains to alternative non-antibiotic agents: lysostaphin, nisin and polymyxin B.

2014

Bee Bread Exhibits Higher Antimicrobial Potential Compared to Bee Pollen

2021
Meta Tagi